Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 9/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 8/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | CASP2 | P42575 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28891444 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL28059419 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL8587015 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL29047889 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL9029626 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL11032495 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL8741361 | 0.98 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 | |
| SCHEMBL11293176 | 0.93 | — | — | |
| SCHEMBL6836206 | 0.88 | TSHR (0.35) | HDAC1HDAC3HDAC2HDAC11HDAC8 | |
| SCHEMBL31486286 | 0.88 | EPHX1 (0.50) | HDAC1HDAC3HDAC2EPHX1HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108948303-B | Material based on porous polyacylsemicarbazide, preparation method and application | 中国科学院大连化学物理研究所 | 2020-10-02 | — | — | CN | claimed |
| EP-2582666-B1 | ARYL SUBSTITUTED INDOLES AND THEIR USE AS BLOCKERS OF SODIUM CHANNELS | PURDUE PHARMA LP (US) | 2014-08-13 | — | — | EP | claimed |
| US-8372894-B2 | Method for producing a radiation on grafted polymer | BELENOS CLEAN POWER HOLDING AG (CH) | 2013-02-12 | — | — | US | claimed |
| CN-102216354-A | Process for preparing radiation graft polymers | BELENOS CLEAN POWER HOLDING AG | 2011-10-12 | — | — | CN | claimed |
| US-20110245365-A1 | METHOD FOR PRODUCING A RADIATION GRAFTED POLYMER | BELENOS CLEAN POWER HOLDING AG (CH) | 2011-10-06 | — | — | US | claimed |
| US-20110207726-A1 | Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-08-25 | — | — | US | claimed |
| WO-2009136997-A2 | INHIBITORS OF HUMAN CATHEPSIN L, CATHEPSIN B, AND CATHEPSIN S | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-11-12 | — | — | WO | claimed |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | CANO IVAN COLLADO | 2009-03-05 | — | — | US | claimed |
| US-7455959-B2 | Photographic element containing a speed-enhancing compound | EASTMAN KODAK COMPANY (US) | 2008-11-25 | — | — | US | claimed |
| US-20080248433-A1 | PHOTOGRAPHIC ELEMENT CONTAINING A SPEED-ENHANCING COMPOUND | NPEC INC. | 2008-10-09 | — | — | US | claimed |
| US-5508421-A | Pyrrolotriazole azomethine dye, and heat transfer dye providing material containing a pyrrolotriazole azomethine dye | FUJI PHOTO FILM CO., LTD. (JP) | 1996-04-16 | — | — | US | claimed |
| US-5498772-A | SUBSTRATE WITH HEAT SENSITIVE LAYER AND OPTICAL RECORDING LAYER | MITSUBISHI PAPER MILLS LIMITED (JP) | 1996-03-12 | — | — | US | claimed |
| EP-0433853-B1 | Use of 1-aryl semicarbazides for stabilisation of enzyme substrates, corresponding procedure and diagnostic means containing such stabiliser | BOEHRINGER MANNHEIM GMBH (DE) | 1995-08-16 | — | — | EP | claimed |
| US-5391482-A | Method and diagnostic agent for enzyme substrate stabilization using 1-arylsemicarbazides | BOEHRINGER MANNHEIM GMBH (DE) | 1995-02-21 | — | — | US | claimed |
| US-5334505-A | For colorimetric determination of hydrolases | BOEHRINGER MANNHEIM GMBH (DE) | 1994-08-02 | — | — | US | claimed |
| WO-1992000748-A1 | POLY(ALKYLENE OXIDE) AMINO ACID COPOLYMERS AND DRUG CARRIERS AND CHARGED COPOLYMERS BASED THEREON | ENZON, INC. (US) | 1992-01-23 | — | — | WO | claimed |
| EP-0433853-A1 | Use of 1-aryl semicarbazides for stabilisation of enzyme substrates, corresponding procedure and diagnostic means containing such stabiliser | Roche Diagnostics GmbH (DE) | 1991-06-26 | — | — | EP | claimed |
| EP-0166389-B1 | NEW TETRACYCLO COMPOUNDS, A PROCESS FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-05-23 | — | — | EP | claimed |
| EP-0301946-A1 | Process for the preparation of 1,2,4-triazol-3-ones | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1989-02-01 | — | — | EP | claimed |
| US-4220713-A | Stabilized diagnostic agent | BOEHRINGER MANNHEIM GMBH (DE) | 1980-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207726-A1 | Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S | CTSB, CTSS, CTSV | HDAC1 375/4885HDAC3 716/4885HDAC2 464/4885 |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | PPARG, PPARA, PPARD | HDAC1 894/4885HDAC3 99/4885HDAC2 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.